Anselm Kampik
Papers
1
Total Citations
52
H-Index
1
About
Anselm Kampik is a pioneering ophthalmologist whose research has transformed the treatment of uveal melanoma, a rare but serious intraocular cancer. His key contributions lie in the development of non-invasive, high-precision radiosurgical techniques that spare patients from traditional enucleation or invasive procedures. In his landmark 2008 study, cited over 50 times, Kampik introduced a streamlined, frameless robotic radiosurgery method completed in under three hours under retrobulbar anesthesia—eliminating the need for rigid head immobilization. This work demonstrated the feasibility and safety of delivering targeted radiation to medium-sized melanomas (3–5 mm prominence) with remarkable accuracy, significantly reducing treatment time and patient discomfort. Beyond this breakthrough, Kampik has advanced the understanding of ocular tumor biology and image-guided therapy, influencing clinical protocols worldwide. His research has been instrumental in shifting the paradigm toward organ-preserving, outpatient-based care for uveal melanoma patients. With a career marked by innovation in radiosurgery and ophthalmic oncology, Kampik’s work continues to guide surgeons and researchers seeking safer, more effective treatments for sight-threatening malignancies.
Research Focus
Key Achievements
Top Papers
- 1